局部晚期食管鳞状细胞癌放疗诱导淋巴细胞减少后的淋巴细胞恢复:与预后及淋巴细胞相关器官的相关性
本研究从前瞻性试验中筛选接受根治性同步放化疗后6个月可获取绝对淋巴细胞计数(ALC)的食管鳞状细胞癌(ESCC)患者232例,按放疗期间ALC最低值分级(G4或G1-3)及淋巴细胞恢复状态(淋巴细胞恢复指数LRI<60%为不足,≥60%为满意)分组,Cox分析显示淋巴细胞恢复不足与更差的总生存和局部无复发生存显著相关,logistic分析显示骨髓V5是淋巴细胞恢复不足的独立预测因素。
要点
- 在G4 ALC最低值组和G1-3组中,LRI<60%均与更差的总生存和局部无复发生存显著相关。
- 骨髓V5是G4或G1-3 ALC最低值患者淋巴细胞恢复不足的独立预测因素。
- 淋巴细胞恢复状态可能作为ESCC患者dCCRT后的预后因素。
核心结论
- 淋巴细胞恢复不足可能作为有价值的预后因素,无论患者放疗期间是否出现G4或G1-3 ALC最低值。
- 观察到接受≥5 Gy的相对骨髓体积较大与淋巴细胞恢复不足风险较高相关。
研究设计与样本
- 从前瞻性试验中筛选接受根治性同步放化疗后6个月可获取ALC的ESCC患者232例。
- 按放疗期间ALC最低值分级分为G4组(69例,A组和B组)和G1-3组(163例,C组和D组),再按LRI(治疗后与治疗前淋巴细胞计数比值)分为恢复不足(LRI<60%)和恢复满意(LRI≥60%)。
- 采用Cox分析评估淋巴细胞恢复状态的预后意义,采用logistic分析评估骨髓和脾脏照射相对体积及免疫细胞有效剂量(EDIC)对淋巴细胞恢复状态的影响。
主要发现
- G4 ALC最低值组中,27例(A组)为淋巴细胞恢复不足(LRI<60%),42例(B组)为恢复满意(LRI≥60%)。
- G1-3 ALC最低值组中,67例(C组)为恢复不足(LRI<60%),96例(D组)为恢复满意(LRI≥60%)。
- Cox多变量分析显示,淋巴细胞恢复不足与更差的总生存显著相关,A组 vs B组 HR为2.80,C组 vs D组 HR为1.70。
- Cox多变量分析显示,淋巴细胞恢复不足与更差的局部无复发生存显著相关,A组 vs B组 HR为2.82,C组 vs D组 HR为1.60。
- Logistic分析确定骨髓V5为G4 ALC最低值(OR 4.24)和G1-3 ALC最低值(OR 2.29)患者淋巴细胞恢复不足的独立预测因素。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Limited studies explored the relationship between lymphocyte recovery after definitive concurrent chemoradiotherapy (dCCRT) and prognosis in esophageal squamous cell carcinoma (ESCC). METHODS: ESCC patients with obtainable absolute lymphocyte counts (ALCs) at 6 months after dCCRT were screened from prospective trials. Patients were divided into groups according to the grade of ALC nadir during radiotherapy (G4 or G1-3) and lymphocyte recovery status, which was assessed by lymphocyte recovery index (LRI), calculated as the ratio of post- to pre-treatment lymphocyte counts. Cox analysis was conducted to evaluate the prognostic significance of lymphocyte recovery status. Irradiated relative volumes of the bone marrow (BM) and spleen and effective dose to immune cells (EDIC) were collected to identify their impacts on lymphocyte recovery status by logistic analysis. RESULTS: 232 patients were enrolled. In 69 patients with G4 ALC nadir (group A and B) and 163 patients with G1-3 ALC nadir (group C and D) during dCCRT, 27 (group A) and 67 (group C) patients showed an insufficient level of lymphocyte recovery (LRI < 60%), and 42 (group B) and 96 (group D) patients showed a satisfactory level of lymphocyte recovery (LRI ≥ 60%). Cox multivariable analysis revealed that inadequate lymphocyte recovery was significantly associated with worse overall survival (HR, 2.80 and 1.70) and local recurrence-free survival (HR, 2.82 and 1.60) both in group A vs group B and group C vs group D. Logistic analysis identified BM V5 (OR 4.24 and 2.29) as an independent predictor of inadequate lymphocyte recovery from G4 or G1-3 ALC nadir, respectively. CONCLUSIONS: Insufficient lymphocyte recovery might serve as a valuable prognostic factor, regardless of whether patients experienced G4 or G1-3 ALC nadir during radiotherapy. Additionally, it was observed that a larger relative volume of BM receiving ≥ 5 Gy was correlated with a higher risk of insufficient lymphocyte recovery.
引用
- Tseng I, Ai D, Chen Y, et al. Lymphocyte recovery from radiation-induced lymphopenia in locally advanced esophageal squamous cell carcinoma: correlations with prognosis and lymphocyte-related organs. Radiat Oncol. 2023. PMID: 37858121. doi:10.1186/s13014-023-02354-w
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。